Immobilization and controlled release of prostaglandin E2 from poly-L-lactide-co-glycolide microspheres

Journal of Biomedical Materials Research - Part A

Volumn 91, Issue 2, 2009, Pages 454-462

  Brochhausen, Christoph ^a   Zehbe, Rolf ^b   Watzer, Bernhard ^c   Halstenberg, Sven ^a   Gabler, Franziska ^b   Schubert, Helmut ^b   Kirkpatrick, Charles James ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Kinetic; PLGA microspheres; Prolonged release; Prostaglandin; Tissue engineering

Indexed keywords

ANGIOGENESIS; ARACHIDONIC ACIDS; BIOMEDICAL APPLICATIONS; CHONDROCYTE PROLIFERATION; CONTROLLED RELEASE; COSOLVENTS; GAS CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; GC/MS/MS; GLYCOLIDE; IN-SITU; IN-VITRO; LIFE-TIMES; PATHOPHYSIOLOGICAL; PHYSIOLOGICAL CONDITION; PHYSIOLOGICAL HOMEOSTASIS; PLGA MICROSPHERES; POLY-L-LACTIDE; PROLONGED RELEASE; PROSTAGLANDIN; PROSTAGLANDINE; SERUM-FREE MEDIUM; SIGNALING MOLECULES; STIMULATING EFFECTS; TIME POINTS;

BODY FLUIDS; CHROMATOGRAPHIC ANALYSIS; EMULSIFICATION; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; MICROSPHERES; ORGANIC POLYMERS; ORGANIC SOLVENTS; SCANNING ELECTRON MICROSCOPY;

TISSUE ENGINEERING;

HEXAFLUORO 2 PROPANOL; MICROSPHERE; ORGANIC SOLVENT; POLYGLACTIN; POLYVINYL ALCOHOL; PROSTAGLANDIN E2;

ARTICLE; CULTURE MEDIUM; EMULSION; IMMOBILIZATION; PARTICLE SIZE; PROSTAGLANDIN RELEASE; SURFACE PROPERTY;

DELAYED-ACTION PREPARATIONS; DINOPROSTONE; KINETICS; MICROSPHERES; PARTICLE SIZE; POLYGLACTIN 910;

EID: 70349470990     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32215     Document Type: Article

References (40)

1. Sharma B, Elisseeff JH. Engineering structurally organized cartilage and bone tissue. Ann Biomed Eng 2004;32:148-159.
2. Gunatillake PA, Adhikari R. Biodegradable synthetic polymers for tissue Engineering. Eur Cell Mater 2003;5:1-16. (Pubitemid 38957397)
3. Nicoll SB, Denker AE, Tuan RS. Mesenchymal cell-based repair of connective tissue defects: Application of transforming growth factor-β superfamily members and biodegradable polymer scaffolds. Cell Mater 1998;8:99-122.
4. Vane JR, Bakhle YS, Botting RM. Cyclooxygenase 1 and 2. Ann Rev Pharmacol Toxicol 1998;38:97-120.
5. Pai R, Szabo IL, Soreghan BA, Atay S, Kawanaka H, Tarnawski AS. PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways. Biochem Biophys Res Commun 2001;286:923-928.
6. Luo JC, Shin VY, Liu ESL, Ye YN, Wu WK, So WH, Chang FY, Cho CH. Dexamethasone delays ulcer healing by inhibition of angiogenesis in rat stomachs. Eur J Pharmacol 2004;485:275-281.
7. Kirkpatrick CJ, Fuchs S, Peters K, Brochhausen C, Hermanns IM, Unger R. Visions for regenerative medicine: Interface between scientific fact and science fiction. Artif Organs 2006;30:822-827. (Pubitemid 44521375)
8. Carano RA, Filvaroff EH. Angiogenesis and bone repair. Drug Discov Today 2003;8:980-989.
9. Li M, Thompson DD, Paralkar VM. Prostaglandin E2 receptors in bone formation. Int Orthop 2007;31:767-772.
10. Keller J, Bunger C, Andreassen TT, Bak B, Luch U. Bone repair inhibited by indomethacin. Effects on bone metabolism and strength of rabbit osteotomies. Acta Orthop Scand 1987;58:379-383.
11. Li M, Ke HZ, Qi H, Healy DR, Li Y, Crawford DT, Paralkar VM, Owen TA, Cameron KO, Lefker BA, Brown TA, Thompson DD. A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing. J Bone Miner Res 2003;18:2033-2042. (Pubitemid 37377454)
12. Brochhausen C, Neuland P, Kirkpatrick CJ, Nusing RM, Klaus G. Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ - Prostaglandin E2 dependent proliferation of growth plate chondrocytes. Arthritis Res Ther 2006;8:R78.
13. Jakob M, Démarteau O, Suetterlin R, Heberer M, Martin I. Chondrogenesis of expanded adult human articular chondrocytes is enhanced by specific prostaglandins. Rheumatology 2004;43:852-857. (Pubitemid 38996958)
14. Arikawa T, Omura K, Morita I. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J Cell Physiol 2004;200:400-406. (Pubitemid 39006932)
15. Paralkar VM, Grasser WA, Mansolf AL, Baumann AP, Owen TA, Smock SL, Martinovic S, Borovecki F, Vukicevic S, Ke HZ, Thompson DD. Regulation of BMP-7 expression by retinoic acid and prostaglandin E(2). J Cell Physiol 2002;190:207-217. (Pubitemid 34027823)
16. Brochhausen C, Zehbe R, Gross U, Schubert H, Kirkpatrick CJ. Perspectives fort the tissue engineering of cartilage from a biological and biomaterial point of view. J Appl Biomat Biomech 2007;5:70-81. (Pubitemid 47606301)
17. Bygdeman M. Pharmacokinetics of prostaglandins. Best Pract Res Clin Obstet Gynaecol 2003;17:707-716.
18. Ghodgaonkar RB, Dubin NH, Blake DA, King DM. 13,14-dihydro-15-keto- prostaglandin F2alpha concentrations in human plasma and amniotic fluid. Am J Obstet Gynecol 1979;134:265-269. (Pubitemid 9218522)
19. Gabler F, Frauenschuh S, Ringe J, Brochhausen C, Goetz P, Kirkpatrick CJ, Sittinger M, Schubert H, Zehbe R. Emulsion-based synthesis of PLGA-microspheres for the in vitro expansion of porcine chondrocytes. Biomol Eng 2007;24:515-520. (Pubitemid 350123183)
20. Schweer H, Watzer B, Seyberth HW. Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry. J Chromatogr 1994;11:221-1217
21. Kanamaru K, Waga S, Kuga Y, Nakamura F, Kamata N. Transcranial Doppler pattern after intracarotid papaverine and prostaglandin E1 incorporated in lipid microsphere in patients with vasospasm. Neurol Med Chir (Tokyo) 1998;38:152-155. (Pubitemid 28551376)
22. Gombotz WR, Pankey SC, Boucherd LS, Phan DK, Puolakkainen PA. Stimulation of bone healing by transforming growth factor-beta 1 released from polymeric or ceramic implants. J Appl Biomater 1994;5:141-150.
23. Ferguson D, Davis WL, Urist MR, Hurt WC, Allen EP. Bovine bone morphogenetic protein (bBMP) fraction-induced repair of craniotomy defects in the rhesus monkey (Macaca speciosa). Clin Orthop Rel Res 1987;219:251-258.
24. Johnson EE, Urist MR, Fineraman GA. Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. Clin Orthop Rel Res 1988;230:257-265.
25. King TW, Patrick CW Jr. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. J Biomed Mater Res 2000;51:383-390.
26. Görner T, Gref R, Michenot D, Sommer F, Tran MN, Dellacherie E. Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J Control Release 1999;57:259-268.
27. Alonso MJ, Cohen S, Park TG, Gupta RK, Siber GR, Langer R. Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm Res 1993;10:945-953. (Pubitemid 23211414)
28. Mandal TK, Lopez-Anaya A, Onyebueke E, Shekleton M. Preparation of biodegradable microcapsules containing zidovudine (AZT) using solvent evaporation method. J Microencapsul 1996;13:257-267. (Pubitemid 26149537)
29. Cao X, Shoichet MS. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Biomaterials 1999;20:329-339.
30. Cleland JL, Jones AJS. Stable formulations of recombinant human growth hormone and interferon-γ for microencapsulation in biodegradable microspheres. Pharm Res 1996;13:1464-1475.
31. Carino GP, Jacob JS, Mathiowitz E. Nanosphere based oral insulin delivery. J Control Release 2000;65:261-269. (Pubitemid 30122931)
32. Beck LR, Pop VZ, Flowers CE, Cowsar DR, Tice TR, Lewis DH, Dunn RL, Moore AB, Gilley RM. Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: An injectable biodegradable contraceptive. Biol Reprod 1983;28:186-195.
33. Nakamura T, Hitomi S, Watanabe S, Shimizu Y, Jamshidi K, Hyon S-H, Ikada Y. Bioabsorption of polylactides with different molecular properties. J Biomed Mater Res 1989;23:1115-1130. (Pubitemid 19232078)
34. Hollinger JO, Battistone GC. Biodegradable bone repair materials. Synthetic polymers and ceramic. Clin Orthop Relat Res 1986;207:290-305.
35. Athanasiou KA, Niederauer GG, Agrawal CM. Strelization, toxicity, biocompatibility and clinical applications of polylactide/polyglycolic acid copolymers. Biomaterials 1996;17:93-102.
36. Frazza EJ, Schmitt EE. A new absorbable suture. J Biomed Mater Res Symp 1971;1:43-58.
37. Cima LG, Vacanti JP, Vacanti C, Ingber D, Mooney D, Langer R. Tissue engineering by transplantation using degradable polymer substrates. J Biomech Eng 1991;113:143-151.
38. Freed LE, Grande DA, Lingbin Z, Emmanual J, Marquis JC, Langer R. Joint resurfacing using allograft chondrocytes and synthetic biodegradable polymer scaffolds. J Biomed Mater Res 1994;27:11-23. (Pubitemid 24237852)
39. Kang SW, Yang HS, Seo SW, Han DK, Kim BS. Apatite-coated poly(lactic-co-glycosid acid) microspheres as an injectable scaffold for bone tissue engineering. J Biomed Mater Res A 2008;85:747-756.
40. Shin M, Abukawa H, Troulis MJ, Vacanti JP. Development of a biodegradable scaffold with interconnected pores by heat fusion and its application to bone tissue engineering. J Biomed Mater Res A 2007;84:702-709. (Pubitemid 351237787)